Person:
Elkhatib, Walid F.

Profile Picture
Email Address
Birth Date
ORCID
0000-0001-5815-3200
SCOPUS
56593725900
Research Projects
Organizational Units
Name
Walid F. Elkhatib
Last Name
Elkhatib
First Name
Walid F.
Main Affiliation
Galala University
Job Title
Professor Head of Microbiology Departmen

Filters

20212
11
2
Reset filters

Settings

Author: Elkhatib, Walid F. × Author: Elleboudy, Nooran Sherif ×

Search Results

Now showing 1 - 2 of 2
  • Publication
    Metadata only
    Improvement of caffeic acid biotransformation into para‐hydroxybenzoic acid by CI‐24 via gamma irradiation and model‐based optimization.
    (John Wiley & Sons, 2021-04-19) Singab, Raghda Abdelnasser; Elleboudy, Nooran Sherif; Yassein, Mahmoud Abdulmegead; Hassouna, Nadia Adelhaleem; Elkhatib, Walid F.
    Para-hydroxybenzoic acid (PHBA) has great potential in biological applications due to its putative antiviral activity against SARS-CoV-2 and its antimicrobial activity in the face of the radically increasing number of multidrug-resistant pathogens. This is in addition to its antimutagenic, anti-inflammatory, antioxidant, hypoglycemic, antiestrogenic, and antiplatelet aggregating activities. In this study, an approximate sixfold increase in the production of PHBA was achieved via biotransformation of caffeic acid by Candida albicans. The improvement was performed in two steps: first, through mutation by gamma irradiation (5 KGy dose), resulting in the recovery of a mutant (CI-24), which produced approximately triple the amount of PHBA produced by the wild-type isolate. Then, biotransformation by this mutant was further optimized via response surface methodology model-based optimization. The maximum PHBA production (7.47 mg/mL) was obtained in a fermentation medium composed of 1% w/v yeast extract as a nitrogen source, with an initial pH of 6.6, incubated at 28 °C at an agitation rate of 250 rpm. To further enhance the performance and economics of the process, cells of the CI-24 mutant were immobilized in calcium alginate beads and could retain an equivalent biotransformation capacity after three successive biotransformation cycles.
  • Publication
    Open Access
    Multidrug Resistant Acinetobacter baumannii Biofilms: Evaluation of Phenotypic–Genotypic Association and Susceptibility to Cinnamic and Gallic Acids
    (Frontiers Media, 2021-09-17) Sherif, Mahmoud M.; Khalaf, Wafaa S.; Elleboudy, Nooran Sherif; Abdelaziz, Neveen A.; Elkhatib, Walid F.
    Acinetobacter baumannii armed with multidrug resistance (MDR) and biofilm-forming ability is increasingly recognized as an alarming pathogen. A deeper comprehension of the correlation between these two armories is required in circumventing its infections. This study examined the biofilm-forming ability of the isolates by crystal violet staining and the antibiotic susceptibility by broth microdilution method. The genetic basis of the MDR and biofilm-forming phenotypes was screened by polymerase chain reaction. The antimicrobial activities of cinnamic and gallic acids against planktonic cells and biofilms of A. baumannii were investigated, and the findings were confirmed with scanning electron microscopy (SEM). Among 90 A. baumannii isolates, 69 (76.6%) were MDR, and all were biofilm formers; they were classified into weak (12.2%), moderate (53.3%), and strong (34.5%) biofilm formers. Our results underlined a significant association between MDR and enhanced biofilm formation. Genotypically, the presence of blaVIM and blaOXA–23 genes along with biofilm-related genes (ompA, bap, and csuE) was statistically associated with the biofilm-forming abilities. Impressively, both gallic and cinnamic acids could significantly reduce the MDR A. baumannii biofilms with variable degrees dependent on the phenotype–genotype characteristics of the tested isolates. The current findings may possess future therapeutic impact through augmenting antimicrobial arsenal against life-threatening infections with MDR A. baumannii biofilms.